<DOC>
	<DOCNO>NCT02190552</DOCNO>
	<brief_summary>A.R.I.S.E . post approval observational study use standard care . The purpose study collect information ability EmboTrap device remove blood clot brain , associated performance characteristic clinical outcome . No formal hypothesis test need comparison plan within study . Instead , estimate population parameter interest primary secondary endpoint provide use appropriate confidence interval .</brief_summary>
	<brief_title>Analysis Revascularisation Ischemic Stroke With EmboTrap</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<criteria>The patient patient 's legally authorize representative sign date Informed Consent Form . Aged 18 year 80 year ( inclusive ) . A new focal disabling neurologic deficit consistent acute cerebral ischemia . NIHSS score ≥8 ≤25 . Preictal mRS score 0 1 . Angiographic confirmation occlusion ICA ( include T L occlusion ) , M1 M2 , MCA , BA TICI flow 01 . Confirmation interventionalist , screen CT MRI , treatment site access Neuravi device . The interventionalist estimate least one deployment Neuravi device complete within 5 hour onset symptom , time onset symptom unknown &gt; 5 hour , patient include use image follow criterion : 1 . MRI criterion : ASPECTS 8 10 , , volume diffusion restriction ≤30 mL mismatch perfusion reduction diffusion restriction present . 2 . CT criterion : ASPECTS 8 10 baseline CT CTAsource image , , volume significantly lower CBV ≤30 mL mismatch perfusion reduction low CBV present . Life expectancy le 6 month . Females pregnant lactating . History severe allergy contrast medium . Has suffer stroke past three month . The patient present NIHSS score &lt; 8 &gt; 25 physician assess clinically relevant uninterrupted coma . Use warfarin anticoagulation International Normalized Ratio ( INR ) &gt; 3.0 . Platelet count &lt; 50,000 . Glucose &lt; 50 mg/dL . Heparin use previous 24 hour PTT ACT &gt; 2X normal . Any known hemorrhagic coagulation deficiency . Computed tomography ( CT ) Magnetic Resonance Imaging ( MRI ) evidence recent/ fresh hemorrhage presentation . For basilar artery occlusion , extend early ischemic change confirm pcASPECTS ≤ 7 baseline CT CTAsource image , extensive DWI lesion midbrain pons region pretreatment MRI . Baseline CT MRI show mass effect intracranial tumor ( except small meningioma ) . Excessive arterial tortuosity precludes study device reach target vessel . A proximal stenosis complete occlusion , judge responsible interventionalist , treat safely prevents access occlude vessel Neuravi device . Evidence active infection . Known cancer metastasis Current use cocaine vasoactive substance .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Brain</keyword>
	<keyword>Brain Clot</keyword>
	<keyword>Brain Diseases</keyword>
	<keyword>Brain Infarction</keyword>
	<keyword>Cerebral Ischemia</keyword>
	<keyword>Cerebrovascular Disorders</keyword>
	<keyword>EmboTrap® Revascularization Device</keyword>
	<keyword>EmboTrap</keyword>
	<keyword>Ischemia</keyword>
	<keyword>Ischemic</keyword>
	<keyword>Ischemic Stroke</keyword>
	<keyword>Mechanical Thrombectomy</keyword>
	<keyword>Neurovascular Intervention</keyword>
	<keyword>Revascularization</keyword>
	<keyword>Stent Retriever</keyword>
	<keyword>Stroke</keyword>
	<keyword>Vascular Diseases</keyword>
</DOC>